Skip to main content
Terug
Watch Compare

Imunon, Inc.

Datakwaliteit: 83%
IMNN
NASDAQ Manufacturing Chemicals
€ 2,92
▼ € 0,14 (-4,58%)
Marktkapitalisatie: 11,95 M
Prijs
€ 3,05
Marktkapitalisatie
11,95 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -14,18 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-430,02%
Onder sectorgemiddelde (-54,01%)
ROIC-280,21%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio1,73
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-0,82 | -0,93
Boven sectorgemiddelde (-1,49)
P/B Ratio2,93
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -1,5
P/B 2,9 1,6
ROE % -430,0 -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

4 analisten
Buy
Huidig
€ 2,92
+636.3%
Koersdoel
€ 21,50
€ 12,00
€ 20,50
€ 33,00
Vooruitzicht
Forward K/W -0,93
Forward WPA -€ 3,14
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 3,14
-€ 5,55 – -€ 1,75
 0,0 3
FY2026 -€ 3,11
-€ 4,14 – -€ 2,45
 0,0 3

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 1,82 -€ 1,30 +28,6%
Q32025 -€ 1,82 -€ 1,16 +36,4%
Q22025 -€ 4,34 -€ 1,87 +56,9%
Q12025 -€ 4,66 -€ 3,65 +21,7%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -14,50 M
ROE -430,02% ROA -163,08%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -14,18 M
ROIC -280,21% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,73
Interest Coverage N/A Asset Turnover N/A
Working Capital 3,06 M Tangible Book Value 4,08 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,82 Forward P/E -0,93
P/B Ratio 2,93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -118,59%
Market Cap 11,95 M Enterprise Value 6,70 M
Per Share
EPS (Diluted TTM) -6,83 Revenue / Share N/A
FCF / Share -3,61 OCF / Share -3,54
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 97,81%
SBC-Adj. FCF -14,53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 500.000,0 500.000,0 500.000,0
Net Income -14,50 M -18,62 M -19,51 M -35,90 M -20,77 M
EPS (Diluted) -6,83 -1,62 -2,16 — —
Gross Profit — — — — —
Operating Income -14,65 M -19,13 M -21,03 M -24,92 M -21,01 M
EBITDA — — — — —
R&D Expenses 7,78 M 11,64 M 11,29 M 11,73 M 10,62 M
SG&A Expenses — — — — —
D&A — 240.000,0 248.000,0 731.629,0 702.918,0
Interest Expense — 197.080,0 197.080,0 5,03 M 569.881,0
Income Tax — -1,28 M -1,28 M -1,57 M -1,38 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12,29 M 9,72 M 21,92 M 43,98 M 74,05 M
Total Liabilities 5,23 M 5,47 M 8,53 M 14,65 M 18,25 M
Shareholders' Equity 7,06 M 4,24 M 13,39 M 29,33 M 55,80 M
Total Debt — — — 5,96 M 5,85 M
Cash & Equivalents 8,78 M 5,87 M 5,84 M 11,49 M 19,59 M
Current Assets 10,72 M 8,01 M 18,24 M 37,15 M 51,95 M
Current Liabilities 4,62 M 4,79 M 7,39 M 10,04 M 6,77 M